newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Announces Expiration and Results of Rights Offering

DUBLIN and CHICAGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (the "Company"), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to